IL6 and infection: We hypothesize that timely interferon-regulated antiviral responses are critical determinants of outcome in primary infections, whereas inflammatory mediators and regulators of antibody-dependent enhancement, including IL-6, IL-8, and IL-10 may dominate in secondary infections.